Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec;9(6):3694-3697.
doi: 10.1002/ehf2.14113. Epub 2022 Aug 24.

Time to rechallenge primary prevention ICD guidelines

Bethany Wong  1   2 , Kenneth McDonald  1   2 , David Keane  1
Affiliations
Editorial

Time to rechallenge primary prevention ICD guidelines

Bethany Wong et al. ESC Heart Fail. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

K McDonald: Consulting fees for Novartis.

References

    1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial III . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–883. - PubMed
    1. Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, Dargie HJ, Granger CB, Kjekshus J, Kober L, Latini R, Maggioni AP, Packer M, Pitt B, Solomon SD, Swedberg K, Tavazzi L, Wikstrand J, Zannad F, Zile MR, McMurray JJV. Declining risk of sudden death in heart failure. N Engl J Med 2017; 377: 41–51. - PubMed
    1. National Institute Health and Care Excellence . NICE guideline: Chronic heart failure in adults: diagnosis and management. https://www.nice.org.uk/guidance/ng106/resources/chronic-heart-failure-i.... Accessed August 15, 2022. - PubMed
    1. Felker GM, Butler J, Ibrahim NE, Piña IL, Maisel A, Bapat D, Camacho A, Ward JH, Williamson KM, Solomon SD, Januzzi JL, PROVE‐HF Investigators . Implantable cardioverter‐defibrillator eligibility after initiation of sacubitril/valsartan in chronic heart failure: Insights from PROVE‐HF. Circulation 2021; 144: 180–182. - PMC - PubMed
    1. Curtain JP, Docherty KF, Jhund PS, Petrie MC, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Bengtsson O, Langkilde AM, Sjostrand M, Solomon SD, McMurray JJV. Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA‐HF. Eur Heart J 2021; 42: 3727–3738. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources